
Sign up to save your podcasts
Or


Dr Bauchner, Editor in Chief of JAMA, provides summary and commentary on the April 4, 2012 issue of JAMA, the Journal of the American Medical Association. Cetuximab and Stage III Colon Cancer Survival, Screening Ultrasound or MRI for Breast Cancer, Diagnostic Coding and Trends in Pneumonia Outcomes, Fluoroquinolones and Risk of Retinal Detachment, Management of Ovarian Cancer, Financial incentives in health care, Individualized breast cancer treatment.
By JAMA Network3.9
126126 ratings
Dr Bauchner, Editor in Chief of JAMA, provides summary and commentary on the April 4, 2012 issue of JAMA, the Journal of the American Medical Association. Cetuximab and Stage III Colon Cancer Survival, Screening Ultrasound or MRI for Breast Cancer, Diagnostic Coding and Trends in Pneumonia Outcomes, Fluoroquinolones and Risk of Retinal Detachment, Management of Ovarian Cancer, Financial incentives in health care, Individualized breast cancer treatment.

319 Listeners

698 Listeners

496 Listeners

168 Listeners

885 Listeners

295 Listeners

3,345 Listeners

1,148 Listeners

193 Listeners

92 Listeners

513 Listeners

369 Listeners

247 Listeners

424 Listeners

373 Listeners